1. Home
  2. WST vs KB Comparison

WST vs KB Comparison

Compare WST & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • KB
  • Stock Information
  • Founded
  • WST 1923
  • KB 2008
  • Country
  • WST United States
  • KB South Korea
  • Employees
  • WST N/A
  • KB N/A
  • Industry
  • WST Medical/Dental Instruments
  • KB Commercial Banks
  • Sector
  • WST Health Care
  • KB Finance
  • Exchange
  • WST Nasdaq
  • KB Nasdaq
  • Market Cap
  • WST 15.6B
  • KB 29.7B
  • IPO Year
  • WST N/A
  • KB N/A
  • Fundamental
  • Price
  • WST $220.98
  • KB $85.54
  • Analyst Decision
  • WST Buy
  • KB
  • Analyst Count
  • WST 7
  • KB 0
  • Target Price
  • WST $331.67
  • KB N/A
  • AVG Volume (30 Days)
  • WST 615.3K
  • KB 221.2K
  • Earning Date
  • WST 07-24-2025
  • KB 07-22-2025
  • Dividend Yield
  • WST 0.38%
  • KB 2.22%
  • EPS Growth
  • WST N/A
  • KB 44.35
  • EPS
  • WST 6.37
  • KB 9.87
  • Revenue
  • WST $2,895,800,000.00
  • KB $10,140,169,514.00
  • Revenue This Year
  • WST $3.38
  • KB $16.73
  • Revenue Next Year
  • WST $5.82
  • KB $2.12
  • P/E Ratio
  • WST $34.74
  • KB $8.36
  • Revenue Growth
  • WST N/A
  • KB 12.28
  • 52 Week Low
  • WST $187.43
  • KB $46.38
  • 52 Week High
  • WST $352.33
  • KB $89.45
  • Technical
  • Relative Strength Index (RSI)
  • WST 49.84
  • KB 61.90
  • Support Level
  • WST $219.60
  • KB $84.06
  • Resistance Level
  • WST $233.84
  • KB $89.45
  • Average True Range (ATR)
  • WST 5.32
  • KB 1.35
  • MACD
  • WST 0.04
  • KB -0.21
  • Stochastic Oscillator
  • WST 29.22
  • KB 58.57

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About KB KB Financial Group Inc

KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.

Share on Social Networks: